Literature DB >> 23790174

Clinical significance of ascites in epithelial ovarian cancer.

H Huang1, Y J Li, C Y Lan, Q D Huang, Y L Feng, Y W Huang, J H Liu.   

Abstract

The prognostic significance of ascites in the dissemination of metastases in epithelial ovarian cancer (EOC) is unclear. Our study aimed to investigate the association between clinicopathological factors and the development of ascites, as well as its prognostic significance. Three hundred and thirty three patients with primary EOC were suitable for inclusion. We analyzed the correlation between clinicopathological factors, including the extent of metastases, and ascitic volume. The prognostic significance of ascites was assessed using the Kaplan-Meier method and multivariate Cox's regression analysis. The average ascitic volume was 1,800 ml. Significantly, more patients with advanced FIGO stage disease presented with ascites. The volume of ascites increased significantly when metastatic disease was present in more than three regions (p<0.05), and this was the sole factor identified as associated with ascitic volume by multiple linear regression analysis. Median survival was significantly different between those with an ascitic volume less than 1,800 ml (median survival = 58 months), and those with a volume greater than 1,800 ml (median survival = 28.6 months) (p<0.05). Subgroup analysis of stage III and IV patients also revealed a poor prognosis in the presence of massive ascites (p = 0.03). Multivariate analyses found that massive ascites and poor differentiation were independent poor prognostic factors for stage III and IV EOC patients by Cox regression, using a backward elimination procedure. The volume of ascites increased significantly with the extent of metastastic disease. Massive ascites and poor tumor differentiation were associated with a worse prognosis in patients with advanced stage ovarian cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23790174     DOI: 10.4149/neo_2013_071

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  19 in total

1.  Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.

Authors:  Kelly L Singel; Tiffany R Emmons; Anm Nazmul H Khan; Paul C Mayor; Shichen Shen; Jerry T Wong; Kayla Morrell; Kevin H Eng; Jaron Mark; Richard B Bankert; Junko Matsuzaki; Richard C Koya; Anna M Blom; Kenneth R McLeish; Jun Qu; Sanjay Ram; Kirsten B Moysich; Scott I Abrams; Kunle Odunsi; Emese Zsiros; Brahm H Segal
Journal:  JCI Insight       Date:  2019-03-07

2.  Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study.

Authors:  J Brian Szender; Tiffany Emmons; Sarah Belliotti; Danielle Dickson; Aalia Khan; Kayla Morrell; A N M Nazmul Khan; Kelly L Singel; Paul C Mayor; Kirsten B Moysich; Kunle Odunsi; Brahm H Segal; Kevin H Eng
Journal:  Gynecol Oncol       Date:  2017-06-16       Impact factor: 5.482

Review 3.  Friend and foe: the regulation network of ascites components in ovarian cancer progression.

Authors:  Zhe Geng; Xinxing Pan; Juan Xu; Xuemei Jia
Journal:  J Cell Commun Signal       Date:  2022-10-13       Impact factor: 5.908

Review 4.  Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components.

Authors:  Militsa Rakina; Anna Kazakova; Alisa Villert; Larisa Kolomiets; Irina Larionova
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

5.  The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms.

Authors: 
Journal:  Ann Surg Oncol       Date:  2020-04-13       Impact factor: 5.344

6.  Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.

Authors:  Lihong Mo; Vendula Pospichalova; Zhiqing Huang; Susan K Murphy; Sturgis Payne; Fang Wang; Margaret Kennedy; George J Cianciolo; Vitezslav Bryja; Salvatore V Pizzo; Robin E Bachelder
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 7.  The untapped potential of ascites in ovarian cancer research and treatment.

Authors:  Caroline Elizabeth Ford; Bonnita Werner; Neville Frederick Hacker; Kristina Warton
Journal:  Br J Cancer       Date:  2020-05-08       Impact factor: 7.640

8.  Ascites promotes cell migration through the repression of miR-125b in ovarian cancer.

Authors:  Lan Yang; Xiaoli Zhang; Yiming Ma; Xinhua Zhao; Bin Li; Hongying Wang
Journal:  Oncotarget       Date:  2017-04-05

9.  Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients.

Authors:  Rodrigo Fernandes da Silva; Adriana Yoshida; Daniela Maira Cardozo; Rodrigo Menezes Jales; Silke Paust; Sophie Derchain; Fernando Guimarães
Journal:  Int J Mol Sci       Date:  2017-05-17       Impact factor: 5.923

10.  Mechanical Modulation of Ovarian Cancer Tumor Nodules Under Flow.

Authors:  Christina Conrad; Kaitlin Moore; William Polacheck; Imran Rizvi; Giuliano Scarcelli
Journal:  IEEE Trans Biomed Eng       Date:  2021-12-23       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.